Drugs / TCA IR
Trials 0
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02762370 Comparator | Apr → Oct 2016 | osteoarthritis, knee, type 2 diabetes mellitus | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 2 | NCT01487200 Comparator | Jul → Nov 2012 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 2 | NCT01487161 Comparator | Jun 2012 → Apr 2013 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TCA IR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02762370 ↗ |
| Known as | Triamcinolone Acetonide | “Single 1 mL intra-articular (IA) injection Immediate-Release Triamcinolone Acetonide” NCT01487161 ↗ |
| Route | Other | “Single 1 mL intra-articular injection” NCT01487161 ↗ |